{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:30:01Z","timestamp":1790890201577,"version":"4.1.0"},"reference-count":341,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["31670782"],"award-info":[{"award-number":["31670782"]}]},{"name":"National Natural Science Foundation of China","award":["31700669"],"award-info":[{"award-number":["31700669"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pathological aggregation of a specific protein into insoluble aggregates is a common hallmark of various neurodegenerative diseases (NDDs). In the earlier literature, each NDD is characterized by the aggregation of one or two pathogenic proteins, which can serve as disease-specific biomarkers. The aggregation of these specific proteins is thought to be a major cause of or deleterious result in most NDDs. However, accumulating evidence shows that a pathogenic protein can interact and co-aggregate with other pathogenic proteins in different NDDs, thereby contributing to disease onset and progression synergistically. During the past years, more than one type of NDD has been found to co-exist in some individuals, which may increase the complexity and pathogenicity of these diseases. This article reviews and discusses the biochemical characteristics and molecular mechanisms underlying the co-aggregation and co-pathologies associated with TDP-43 pathology. The TDP-43 aggregates, as a hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), can often be detected in other NDDs, such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Huntington\u2019s disease (HD) and spinocerebellar ataxia type 2 (SCA2). In many cases, TDP-43 is shown to interact and co-aggregate with multiple pathogenic proteins in vitro and in vivo. Furthermore, the co-occurrence and co-aggregation of TDP-43 with other pathogenic proteins have important consequences that may aggravate the diseases. Thus, the current viewpoint that the co-aggregation of TDP-43 with other pathogenic proteins in NDDs and their relevance to disease progression may gain insights into the patho-mechanisms and therapeutic potential of various NDDs.<\/jats:p>","DOI":"10.3390\/ijms252212380","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T13:03:14Z","timestamp":1731934994000},"page":"12380","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases"],"prefix":"10.3390","volume":"25","author":[{"given":"Lei-Lei","family":"Jiang","sequence":"first","affiliation":[{"name":"Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-8727","authenticated-orcid":false,"given":"Xiang-Le","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China"},{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Hu","sequence":"additional","affiliation":[{"name":"Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Candelise, N., Scaricamazza, S., Salvatori, I., Ferri, A., Valle, C., Manganelli, V., Garofalo, T., Sorice, M., and Misasi, R. (2021). Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116016"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tsoi, P.S., Quan, M.D., Ferreon, J.C., and Ferreon, A.C.M. (2023). Aggregation of Disordered Proteins Associated with Neurodegeneration. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043380"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jnr.10355","article-title":"Alzheimer\u2019s disease: Beta-Amyloid protein and tau","volume":"70","author":"Ihara","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004010050892","article-title":"Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation","volume":"96","author":"Cras","year":"1998","journal-title":"Acta Neuropathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.03-0338rev","article-title":"Alpha-synuclein and Parkinson\u2019s disease","volume":"18","author":"Recchia","year":"2004","journal-title":"FASEB J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","article-title":"Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington\u2019s disease pathology","volume":"96","author":"Scherzinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2013.06.003","article-title":"PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone","volume":"154","author":"Park","year":"2013","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29133","DOI":"10.1073\/pnas.2013552117","article-title":"The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration","volume":"117","author":"Engstrom","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nn.4272","article-title":"C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins","volume":"19","author":"Zhang","year":"2016","journal-title":"Nat. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1111\/febs.13722","article-title":"Sequestration of cellular interacting partners by protein aggregates: Implication in a loss-of-function pathology","volume":"283","author":"Yang","year":"2016","journal-title":"FEBS J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hu, H.-Y., and Liu, Y.-J. (2022). Sequestration of cellular native factors by biomolecular assemblies: Physiological or pathological?. Biochim. Biophys. Acta Mol. Cell Res., 1869.","DOI":"10.1016\/j.bbamcr.2022.119360"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Moda, F., Ciullini, A., Dellarole, I.L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F.A., and Giaccone, G. (2023). Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception. Front. Biosci. Landmark Ed., 28.","DOI":"10.31083\/j.fbl2810255"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kulichikhin, K.Y., Malikova, O.A., Zobnina, A.E., Zalutskaya, N.M., and Rubel, A.A. (2023). Interaction of Proteins Involved in Neuronal Proteinopathies. Life, 13.","DOI":"10.3390\/life13101954"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e22493","DOI":"10.1096\/fj.202200235R","article-title":"Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration","volume":"36","author":"Murakami","year":"2022","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/cjn.2022.34","article-title":"Current Concepts of Mixed Pathologies in Neurodegenerative Diseases","volume":"50","author":"Forrest","year":"2023","journal-title":"Can. J. Neurol. Sci. J. Can. Sci. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/neup.12427","article-title":"Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases","volume":"38","author":"Nonaka","year":"2018","journal-title":"Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.arr.2019.100937","article-title":"Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism","volume":"56","author":"Chaudhuri","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Calabrese, G., Molzahn, C., and Mayor, T. (2022). Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.102062"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Badiola, N., de Oliveira, R.M., Herrera, F., Guardia-Laguarta, C., Gon\u00e7alves, S.A., Pera, M., Su\u00e1rez-Calvet, M., Clarimon, J., Outeiro, T.F., and Lle\u00f3, A. (2011). Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026609"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1093\/hmg\/ddu011","article-title":"Interactions between Tau and alpha-synuclein augment neurotoxicity in a Drosophila model of Parkinson\u2019s disease","volume":"23","author":"Roy","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1084\/jem.20192193","article-title":"alpha-Synuclein modulates tau spreading in mouse brains","volume":"218","author":"Bassil","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1074\/jbc.M116.736355","article-title":"alpha-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly","volume":"291","author":"Oikawa","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1800059","DOI":"10.1002\/pmic.201800059","article-title":"Formation of Heterotypic Amyloids: Alpha-Synuclein in Co-Aggregation","volume":"18","author":"Bhasne","year":"2018","journal-title":"Proteomics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: Acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Gelpi","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_36","first-page":"1203","article-title":"The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/hmg\/ddu606","article-title":"alpha-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila","volume":"24","author":"Herrera","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(00)01247-7","article-title":"Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington\u2019s disease patients and transgenic mouse models","volume":"289","author":"Charles","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3460577","article-title":"Alpha-synuclein overexpression promotes aggregation of mutant huntingtin","volume":"346","author":"Furlong","year":"2000","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease","volume":"135","author":"Turgeon","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.febslet.2011.11.019","article-title":"alpha-Synuclein modifies huntingtin aggregation in living cells","volume":"586","author":"Herrera","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awv107","article-title":"The role of tau in the pathological process and clinical expression of Huntington\u2019s disease","volume":"138","author":"Vuono","year":"2015","journal-title":"Brain J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/hmg\/ddu421","article-title":"Mutant huntingtin alters Tau phosphorylation and subcellular distribution","volume":"24","author":"Blum","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JHD-220557","article-title":"Untangling the Role of Tau in Huntington\u2019s Disease Pathology","volume":"12","author":"Salem","year":"2023","journal-title":"J. Huntingt. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Salem, S., Kilgore, M.D., Anwer, M., Maxan, A., Child, D., Bird, T.D., Keene, C.D., Cicchetti, F., and Latimer, C. (2024). Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington\u2019s disease cases. Neurobiol. Dis., 198.","DOI":"10.1016\/j.nbd.2024.106542"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3724\/abbs.2023081","article-title":"Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis","volume":"55","author":"Hong","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1042\/CBI20090474","article-title":"The composition of the polyglutamine-containing proteins influences their co-aggregation properties","volume":"34","author":"Bak","year":"2010","journal-title":"Cell Biol. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/15548627.2022.2083857","article-title":"A prion-like domain of TFEB mediates the co-aggregation of TFEB and mHTT","volume":"19","author":"Yang","year":"2023","journal-title":"Autophagy"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Fujita, K., Matsubara, T., Miyamoto, R., Sumikura, H., Takeuchi, T., Saladini, K.M., Kawarai, T., Nodera, H., Udaka, F., and Kume, K. (2019). Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: A clinical-pathological case report. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1402-7"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e32452","DOI":"10.1097\/MD.0000000000032452","article-title":"Coexisting amyotrophic lateral sclerosis and chorea: A case report and literature review","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnen\/nlad098","article-title":"Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease","volume":"83","author":"Hiya","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","article-title":"Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: Combined data from 13 community-based or population-based autopsy cohorts","volume":"144","author":"Nelson","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gde.2017.03.011","article-title":"Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease","volume":"44","author":"Pearce","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","article-title":"Intercellular Spread of Protein Aggregates in Neurodegenerative Disease","volume":"34","author":"Davis","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Attems","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., and Patel, B.K. (2019). Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00025"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmb.2005.02.038","article-title":"Human, Drosophila, and C.elegans TDP43: Nucleic acid binding properties and splicing regulatory function","volume":"348","author":"Ayala","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_59","first-page":"86","article-title":"TDP-43 proteinopathies: A new wave of neurodegenerative diseases","volume":"92","author":"Orie","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pinarbasi, E.S., Ca\u011fatay, T., Fung, H.Y.J., Li, Y.C., Chook, Y.M., and Thomas, P.J. (2018). Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-25008-4"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Jiang, L.-L., Xue, W., Hong, J.-Y., Zhang, J.-T., Li, M.-J., Yu, S.-N., He, J.-H., and Hu, H.-Y. (2017). The N-terminal dimerization is required for TDP-43 splicing activity. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06263-3"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Vivoli-Vega, M., Guri, P., Chiti, F., and Bemporad, F. (2020). Insight into the Folding and Dimerization Mechanisms of the N-Terminal Domain from Human TDP-43. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176259"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Carter, G.C., Hsiung, C.-H., Simpson, L., Yang, H., and Zhang, X. (2021). N-terminal Domain of TDP43 Enhances Liquid-Liquid Phase Separation of Globular Proteins. J. Mol. Biol., 433.","DOI":"10.1016\/j.jmb.2021.166948"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbrc.2012.07.071","article-title":"The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity","volume":"425","author":"Chang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-017-00062-0","article-title":"Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation","volume":"8","author":"Afroz","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"36337","DOI":"10.1074\/jbc.M104236200","article-title":"Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9","volume":"276","author":"Buratti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/nar\/gkp013","article-title":"Structural insights into TDP-43 in nucleic-acid binding and domain interactions","volume":"37","author":"Kuo","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1093\/nar\/gkt1407","article-title":"The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids","volume":"42","author":"Kuo","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/nsmb.2698","article-title":"Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43","volume":"20","author":"Lukavsky","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1093\/nar\/gkt189","article-title":"Characterizing TDP-43 interaction with its RNA targets","volume":"41","author":"Bhardwaj","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chien, H.M., Lee, C.C., and Huang, J.J. (2021). The Different Faces of the TDP-43 Low-Complexity Domain: The Formation of Liquid Droplets and Amyloid Fibrils. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158213"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37572","DOI":"10.1074\/jbc.M505557200","article-title":"TDP-43 binds heterogeneous nuclear ribonucleoprotein A\/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing","volume":"280","author":"Buratti","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.biochem.6b01088","article-title":"Phase to Phase with TDP-43","volume":"56","author":"Sun","year":"2017","journal-title":"Biochemistry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19614","DOI":"10.1074\/jbc.M113.463828","article-title":"Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion","volume":"288","author":"Jiang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","article-title":"Rethinking ALS: The FUS about TDP-43","volume":"136","author":"Cleveland","year":"2009","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Jiang, L.-L., Zhao, J., Yin, X.-F., He, W.-T., Yang, H., Che, M.-X., and Hu, H.-Y. (2016). Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation. Sci. Rep., 6.","DOI":"10.1038\/srep23928"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4161\/rna.7.4.12205","article-title":"The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation","volume":"7","author":"Buratti","year":"2010","journal-title":"RNA Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1093\/nar\/gkx175","article-title":"TDP-43 suppresses tau expression via promoting its mRNA instability","volume":"45","author":"Gu","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","article-title":"Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations","volume":"81","author":"Alami","year":"2014","journal-title":"Neuron"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1073\/pnas.1112427109","article-title":"TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes","volume":"109","author":"Kawahara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/emboj.2010.310","article-title":"TDP-43 regulates its mRNA levels through a negative feedback loop","volume":"30","author":"Ayala","year":"2011","journal-title":"EMBO J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1111\/ejn.14762","article-title":"Cytoplasmic localization of amyotrophic lateral sclerosis-related TDP-43 proteins modulates stress granule formation","volume":"52","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Khalfallah, Y., Kuta, R., Grasmuck, C., Prat, A., Durham, H.D., and Velde, C.V. (2018). TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-25767-0"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/hmg\/ddr021","article-title":"TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1","volume":"20","author":"McDonald","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Carey, J.L., and Guo, L. (2022). Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.826719"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/ncomms5824","article-title":"Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients","volume":"5","author":"Fang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1074\/jbc.RA118.005889","article-title":"Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation","volume":"294","author":"French","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Kitamura, A., Fujimoto, A., Kawashima, R., Lyu, Y., Sasaki, K., Hamada, Y., Moriya, K., Kurata, A., Takahashi, K., and Brielmann, R. (2024). Hetero-oligomerization of TDP-43 carboxy-terminal fragments with cellular proteins contributes to proteotoxicity. Commun. Biol., 7.","DOI":"10.1038\/s42003-024-06410-3"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M800342200","article-title":"Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation","volume":"283","author":"Winton","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"van Eersel, J., Ke, Y.D., Gladbach, A., Bi, M., G\u00f6tz, J., Kril, J.J., and Ittner, L.M. (2011). Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022850"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neurobiolaging.2013.07.006","article-title":"Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice","volume":"35","author":"Medina","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1440-1789.2009.01089.x","article-title":"Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy","volume":"30","author":"Arai","year":"2010","journal-title":"Neuropathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"102459","DOI":"10.1016\/j.isci.2021.102459","article-title":"Molecular, functional, and pathological aspects of TDP-43 fragmentation","volume":"24","author":"Chhangani","year":"2021","journal-title":"iScience"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Berning, B.A., and Walker, A.K. (2019). The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00335"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.21425","article-title":"Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"64","author":"Hasegawa","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/j.2769-2795.2021.tb00074.x","article-title":"Aberrant TDP-43 phosphorylation: A key wind gap from TDP-43 to TDP-43 proteinopathy","volume":"7","author":"Huang","year":"2021","journal-title":"Ibrain"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1007\/s12035-021-02505-8","article-title":"SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution","volume":"58","author":"Maraschi","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1038\/ncomms6845","article-title":"An acetylation switch controls TDP-43 function and aggregation propensity","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Wood, A., Gurfinkel, Y., Polain, N., Lamont, W., and Rea, S.L. (2021). Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094705"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Doke, A.A., and Jha, S.K. (2023). Shapeshifter TDP-43: Molecular mechanism of structural polymorphism, aggregation, phase separation and their modulators. Biophys. Chem., 295.","DOI":"10.1016\/j.bpc.2023.106972"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","article-title":"Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis","volume":"30","author":"Barmada","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","article-title":"Triad of TDP43 control in neurodegeneration: Autoregulation, localization and aggregation","volume":"22","author":"Tziortzouda","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-024-00735-7","article-title":"Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits","volume":"19","author":"Hu","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Droppelmann, C.A., Campos-Melo, D., Moszczynski, A.J., Amzil, H., and Strong, M.J. (2019). TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-56483-y"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/hmg\/ddt408","article-title":"Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40\/70 chaperones","volume":"23","author":"Bengoechea","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"114421","DOI":"10.1016\/j.celrep.2024.114421","article-title":"Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion","volume":"43","author":"Huang","year":"2024","journal-title":"Cell Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/febs.15159","article-title":"Structural dissection of amyloid aggregates of TDP-43 and its C-terminal fragments TDP-35 and TDP-16","volume":"287","author":"Shenoy","year":"2020","journal-title":"FEBS J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/jacs.9b10736","article-title":"Solid-State NMR Reveals the Structural Transformation of the TDP-43 Amyloidogenic Region upon Fibrillation","volume":"142","author":"Zhuo","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1074\/jbc.M111.288720","article-title":"Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln\/Asn-rich region","volume":"287","author":"Budini","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Sato, T., Oda, K., Sakai, S., Kato, R., Yamamori, S., Itakura, M., Kodera, Y., Nishizawa, M., Sasaoka, T., and Onodera, O. (2022). Importance of the Q\/N-rich segment for protein stability of endogenous mouse TDP-43. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-19153-0"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nsmb.2053","article-title":"An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity","volume":"18","author":"Guo","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1074\/jbc.M112.433615","article-title":"Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins","volume":"288","author":"Watanabe","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Chen, H.J., and Mitchell, J.C. (2021). Mechanisms of TDP-43 Proteinopathy Onset and Propagation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116004"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Tamaki, Y., and Urushitani, M. (2022). Molecular Dissection of TDP-43 as a Leading Cause of ALS\/FTLD. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012508"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Jiang, L., and Ngo, S.T. (2022). Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis. Metabolites, 12.","DOI":"10.3390\/metabo12080709"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.14327","article-title":"Pathomechanisms of TDP-43 in neurodegeneration","volume":"146","author":"Gao","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tins.2021.02.008","article-title":"Connecting TDP-43 Pathology with Neuropathy","volume":"44","author":"Klim","year":"2021","journal-title":"Trends Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4103\/1673-5374.382233","article-title":"The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nn.2779","article-title":"Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43","volume":"14","author":"Polymenidou","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","article-title":"TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A","volume":"603","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1074\/jbc.RA118.007222","article-title":"The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain","volume":"294","author":"Babinchak","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","article-title":"ALS Mutations Disrupt Phase Separation Mediated by alpha-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain","volume":"24","author":"Conicella","year":"2016","journal-title":"Structure"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bpj.2024.01.001","article-title":"Phosphomimetic substitutions in TDP-43\u2019s transiently alpha-helical region suppress phase separation","volume":"123","author":"Haider","year":"2024","journal-title":"Biophys. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1074\/jbc.RA118.006351","article-title":"Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation","volume":"294","author":"Chen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Aulas, A., and Vande Velde, C. (2015). Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS?. Front. Cell. Neurosci., 9.","DOI":"10.3389\/fncel.2015.00423"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.aad2033","article-title":"Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA","volume":"351","author":"Woerner","year":"2016","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","article-title":"TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD","volume":"21","author":"Chou","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2019.02.038","article-title":"Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death","volume":"102","author":"Lu","year":"2019","journal-title":"Neuron"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.celrep.2020.02.078","article-title":"Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes","volume":"30","author":"Sleigh","year":"2020","journal-title":"Cell Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482968.2011.641569","article-title":"Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis","volume":"13","author":"Lautenschlaeger","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Dafinca, R., Barbagallo, P., and Talbot, K. (2021). The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.653688"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Pisciottani, A., Croci, L., Lauria, F., Marullo, C., Savino, E., Ambrosi, A., Podini, P., Marchioretto, M., Casoni, F., and Cremona, O. (2023). Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis. Front. Cell. Neurosci., 17.","DOI":"10.3389\/fncel.2023.1253543"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/hmg\/ddz141","article-title":"Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis","volume":"28","author":"Guerrero","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4103\/1673-5374.338997","article-title":"TDP-35, a truncated fragment of TDP-43, induces dose-dependent toxicity and apoptosis in flies","volume":"17","author":"Chhangani","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","article-title":"TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration","volume":"100","author":"Gao","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/hmg\/ddt528","article-title":"Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models","volume":"23","author":"Cortez","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41594-020-00537-7","article-title":"TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS","volume":"28","author":"Zuo","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Budini, M., Buratti, E., Morselli, E., and Criollo, A. (2017). Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00170"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e53890","DOI":"10.15252\/embr.202153890","article-title":"Gel-like inclusions of C-terminal fragments of TDP-43 sequester stalled proteasomes in neurons","volume":"23","author":"Riemenschneider","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"19437","DOI":"10.1074\/jbc.M116.737726","article-title":"Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies","volume":"291","author":"Cascella","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/brain\/awq111","article-title":"Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration","volume":"133","author":"Nishimura","year":"2010","journal-title":"Brain J. Neurol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00018-023-04739-2","article-title":"Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43","volume":"80","author":"Keating","year":"2023","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.febslet.2015.06.009","article-title":"TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA","volume":"589","author":"Che","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"jcs259380","DOI":"10.1242\/jcs.259380","article-title":"RNA-assisted sequestration of RNA-binding proteins by cytoplasmic inclusions of the C-terminal 35-kDa fragment of TDP-43","volume":"135","author":"Jiang","year":"2022","journal-title":"J. Cell Sci."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Loganathan, S., Lehmkuhl, E.M., Eck, R.J., and Zarnescu, D.C. (2019). To Be or Not To Be\u2026 Toxic-Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration?. Front. Mol. Biosci., 6.","DOI":"10.3389\/fmolb.2019.00154"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"11880","DOI":"10.1093\/nar\/gkaa822","article-title":"RNA as the stone guest of protein aggregation","volume":"48","author":"Louka","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.15252\/embj.201488740","article-title":"TDP-1, the Caenorhabditis elegans ortholog of TDP-43, limits the accumulation of double-stranded RNA","volume":"33","author":"Saldi","year":"2014","journal-title":"EMBO J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","article-title":"Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons","volume":"27","author":"Liu","year":"2019","journal-title":"Cell Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"jcs244129","DOI":"10.1242\/jcs.244129","article-title":"TDP-43 dysfunction results in R-loop accumulation and DNA replication defects","volume":"133","author":"Wood","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1073\/pnas.1818415116","article-title":"Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects","volume":"116","author":"Mitra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_157","first-page":"E1121","article-title":"Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Charif, S.E., Luchelli, L., Vila, A., Blaustein, M., and Igaz, L.M. (2020). Cytoplasmic Expression of the ALS\/FTD-Related Protein TDP-43 Decreases Global Translation Both in vitro and in vivo. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.594561"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddab227","article-title":"Cytoplasmic TDP-43 is involved in cell fate during stress recovery","volume":"31","author":"Lee","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41593-018-0113-5","article-title":"TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD","volume":"21","author":"White","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e98684","DOI":"10.15252\/embj.201798684","article-title":"Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis","volume":"37","author":"Fratta","year":"2018","journal-title":"EMBO J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00401-012-1030-4","article-title":"Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects","volume":"124","author":"Halliday","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.conb.2019.11.018","article-title":"Prion-like properties of assembled TDP-43","volume":"61","author":"Nonaka","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nbd.2016.08.007","article-title":"In vitro prion-like behaviour of TDP-43 in ALS","volume":"96","author":"Smethurst","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","article-title":"Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo","volume":"9","author":"Porta","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","article-title":"Prion-like properties of pathological TDP-43 aggregates from diseased brains","volume":"4","author":"Nonaka","year":"2013","journal-title":"Cell Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1007\/s12035-022-02847-x","article-title":"The Role of TDP-43 in Neurodegenerative Disease","volume":"59","author":"Liao","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2010.18","article-title":"TAR DNA-binding protein 43 in neurodegenerative disease","volume":"6","author":"Lee","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00401-012-1035-z","article-title":"Co-aggregation of RNA binding proteins in ALS spinal motor neurons: Evidence of a common pathogenic mechanism","volume":"124","author":"Keller","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","article-title":"Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: A clinicopathologic study","volume":"124","author":"Tada","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Montalbano, M., McAllen, S., Cascio, F.L., Sengupta, U., Garcia, S., Bhatt, N., Ellsworth, A., Heidelman, E.A., Johnson, O.D., and Doskocil, S. (2020). TDP-43 and Tau Oligomers in Alzheimer\u2019s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Neurobiol. Dis., 146.","DOI":"10.1016\/j.nbd.2020.105130"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-012-0985-5","article-title":"Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions","volume":"124","author":"Hart","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/neup.12057","article-title":"Concomitant alpha-synuclein pathology in an autopsy case of amyotrophic lateral sclerosis presenting with orthostatic hypotension and cardiac arrests","volume":"34","author":"Yamada","year":"2014","journal-title":"Neuropathology"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuron.2020.11.005","article-title":"Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis","volume":"109","author":"Dewan","year":"2021","journal-title":"Neuron"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain J. Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-012-1050-0","article-title":"Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant","volume":"125","author":"King","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00415-018-9086-2","article-title":"Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: Nine case series","volume":"265","author":"Kim","year":"2018","journal-title":"J. Neurol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/neup.12428","article-title":"Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis\/frontotemporal lobar degeneration","volume":"38","author":"Takeda","year":"2018","journal-title":"Neuropathol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain J. Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e1951","DOI":"10.1212\/WNL.0000000000010454","article-title":"Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging","volume":"95","author":"Kapasi","year":"2020","journal-title":"Neurology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-019-0743-1","article-title":"Resistance and resilience to Alzheimer\u2019s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort","volume":"7","author":"Latimer","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/alz.13780","article-title":"Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults","volume":"20","author":"Kapasi","year":"2024","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","article-title":"Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"1184","author":"Higashi","year":"2007","journal-title":"Brain Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e13159","DOI":"10.1111\/bpa.13159","article-title":"TDP-43 and tau concurrence in the entorhinal subfields in primary age-related tauopathy and preclinical Alzheimer\u2019s disease","volume":"33","author":"Oltmer","year":"2023","journal-title":"Brain Pathol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/neup.12938","article-title":"Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer\u2019s disease: A case report spanning 16 years of memory loss","volume":"44","author":"Carlos","year":"2024","journal-title":"Neuropathology"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-021-02295-2","article-title":"TDP-43 interacts with pathological tau protein in Alzheimer\u2019s disease","volume":"141","author":"Gomes","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","article-title":"TDP-43 interacts with amyloid-beta, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease","volume":"11","author":"Shih","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/brain\/awac091","article-title":"Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration","volume":"145","author":"Riku","year":"2022","journal-title":"Brain J. Neurol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnen\/nlz141","article-title":"Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD","volume":"79","author":"Robinson","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","article-title":"Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: A distinct clinicopathologic subtype","volume":"136","author":"Koga","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-008-0463-2","article-title":"Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease","volume":"117","author":"Fujishiro","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jnen\/nlad042","article-title":"The frequency and distribution of TDP-43 pathology in argyrophilic grain disease","volume":"82","author":"Koga","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000287952","article-title":"Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"7","author":"Kokoulina","year":"2010","journal-title":"Neuro-Degener. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JPD-230154","article-title":"Prevalence of Concomitant Pathologies in Parkinson\u2019s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms","volume":"14","author":"Walker","year":"2024","journal-title":"J. Parkinson\u2019s Dis."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Uryu","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","article-title":"Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"117","author":"Arai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-010-0731-9","article-title":"Effect of topographical distribution of alpha-synuclein pathology on TDP-43 accumulation in Lewy body disease","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/nan.12485","article-title":"TDP-43 pathology in multiple system atrophy: Colocalization of TDP-43 and alpha-synuclein in glial cytoplasmic inclusions","volume":"44","author":"Koga","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/mdc3.12823","article-title":"Multiple System Atrophy With Predominant Striatonigral Degeneration and TAR DNA-Binding Protein of 43 kDa Pathology: An Unusual Variant of Multiple System Atrophy","volume":"6","author":"Nwabuobi","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnen\/nlac032","article-title":"Parallel Appearance of Polyglutamine and Transactivation-Responsive DNA-Binding Protein 43 and Their Complementary Subcellular Localization in Brains of Patients With Spinocerebellar Ataxia Type 2","volume":"81","author":"Koyano","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00401-011-0862-7","article-title":"Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology","volume":"122","author":"Toyoshima","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1793-8","article-title":"Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis","volume":"135","author":"Saberi","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00401-020-02176-0","article-title":"Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS","volume":"140","author":"LaClair","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1093\/hmg\/ddx350","article-title":"C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity","volume":"26","author":"Lee","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_210","first-page":"790","article-title":"Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS\/FTLD","volume":"26","author":"Khosravi","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ebiom.2017.06.002","article-title":"Reduced TDP-43 Expression Improves Neuronal Activities in a Drosophila Model of Perry Syndrome","volume":"21","author":"Hosaka","year":"2017","journal-title":"eBioMedicine"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The epidemiology of ALS: A conspiracy of genes, environment and time","volume":"9","author":"Hardiman","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2024.05.001","article-title":"Molecular mechanisms linking loss of TDP-43 function to amyotrophic lateral sclerosis\/frontotemporal dementia-related genes","volume":"208","author":"Koike","year":"2024","journal-title":"Neurosci. Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","article-title":"ALS Genetics: Gains, Losses, and Implications for Future Therapies","volume":"108","author":"Kim","year":"2020","journal-title":"Neuron"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Duranti, E., and Villa, C. (2022). Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010704"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Hosokawa, M., Kondo, H., Serrano, G.E., Beach, T.G., Robinson, A.C., Mann, D.M., Akiyama, H., Hasegawa, M., and Arai, T. (2017). Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-01587-6"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnen\/nlab061","article-title":"Fast Progression in Amyotrophic Lateral Sclerosis Is Associated With Greater TDP-43 Burden in Spinal Cord","volume":"80","author":"Cathcart","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"Mackenzie","year":"2011","journal-title":"Neuron"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"ref_222","first-page":"9","article-title":"RNA Dysmetabolism and Repeat-Associated Non-AUG Translation in Frontotemporal Lobar Degeneration\/Amyotrophic Lateral Sclerosis due to C9orf72 Hexanucleotide Repeat Expansion","volume":"6","author":"Mori","year":"2023","journal-title":"JMA J."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00401-015-1476-2","article-title":"Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers","volume":"130","author":"Mackenzie","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Freibaum, B.D., and Taylor, J.P. (2017). The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00035"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"a024224","DOI":"10.1101\/cshperspect.a024224","article-title":"Disease Mechanisms of C9ORF72 Repeat Expansions","volume":"8","author":"Gendron","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: Multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of Toxicity from ALS\/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn.2016.38","article-title":"The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease","volume":"17","author":"Haeusler","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.celrep.2013.10.049","article-title":"Hexanucleotide repeats in ALS\/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic","volume":"5","author":"Lee","year":"2013","journal-title":"Cell Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1038\/s41467-023-43872-1","article-title":"The ALS\/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes","volume":"14","author":"Raguseo","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS","volume":"126","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1254917","article-title":"Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells","volume":"345","author":"Kwon","year":"2014","journal-title":"Science"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/2051-5960-1-68","article-title":"Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72","volume":"1","author":"Mann","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","article-title":"Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins","volume":"126","author":"Mori","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Schmitz, A., Marques, J.P., Oertig, I., Maharjan, N., and Saxena, S. (2021). Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS\/FTD. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.637548"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-020-02216-9","article-title":"Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases","volume":"140","author":"Dedeene","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-020-00365-9","article-title":"Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS\/FTD","volume":"15","author":"Andrade","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00018-022-04518-5","article-title":"The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates","volume":"79","author":"Pu","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molcel.2019.03.019","article-title":"C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function","volume":"74","author":"White","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"e51685","DOI":"10.7554\/eLife.51685","article-title":"C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import","volume":"9","author":"Hayes","year":"2020","journal-title":"eLife"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41593-024-01589-4","article-title":"PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS\/FTD neurons","volume":"27","author":"Milioto","year":"2024","journal-title":"Nat. Neurosci."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Xu, L., Wang, D., Zhao, L., Yang, Z., Liu, X., Li, X., Yuan, T., Wang, Y., Huang, T., and Bian, N. (2023). C9orf72 poly(PR) aggregation in nucleus induces ALS\/FTD-related neurodegeneration in cynomolgus monkeys. Neurobiol. Dis., 184.","DOI":"10.1016\/j.nbd.2023.106197"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"eaav2606","DOI":"10.1126\/science.aav2606","article-title":"Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity","volume":"363","author":"Zhang","year":"2019","journal-title":"Science"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-019-0310-z","article-title":"Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy","volume":"14","author":"Chew","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"112822","DOI":"10.1016\/j.celrep.2023.112822","article-title":"Poly(GR) interacts with key stress granule factors promoting its assembly into cytoplasmic inclusions","volume":"42","author":"Park","year":"2023","journal-title":"Cell Rep."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.neuron.2024.10.001","article-title":"Interference of nuclear speckles: A nexus of RNA foci, dipeptide repeats, and mis-splicing in C9ORF72 ALS\/FTD","volume":"112","author":"Zhu","year":"2024","journal-title":"Neuron"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"eabb3774","DOI":"10.1126\/scitranslmed.abb3774","article-title":"C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy","volume":"12","author":"Cook","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/hmg\/ddy174","article-title":"C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43","volume":"27","author":"Nonaka","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"e102811","DOI":"10.15252\/embj.2019102811","article-title":"Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS\/FTD","volume":"39","author":"Khosravi","year":"2020","journal-title":"EMBO J."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"108538","DOI":"10.1016\/j.celrep.2020.108538","article-title":"Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions","volume":"33","author":"Hutten","year":"2020","journal-title":"Cell Rep."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1212\/WNL.0b013e31821f445b","article-title":"Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2","volume":"76","author":"Veldink","year":"2011","journal-title":"Neurology"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","article-title":"ATXN2 trinucleotide repeat length correlates with risk of ALS","volume":"51","author":"Sproviero","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/WCO.0000000000000959","article-title":"Ataxin-2 gene: A powerful modulator of neurological disorders","volume":"34","author":"Paucar","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/hmg\/ddr227","article-title":"Ataxin-2 repeat-length variation and neurodegeneration","volume":"20","author":"Ross","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"231.e7","DOI":"10.1016\/j.neurobiolaging.2018.09.009","article-title":"ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia","volume":"73","author":"Rubino","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1212\/WNL.0000000000000778","article-title":"Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders","volume":"83","author":"Lattante","year":"2014","journal-title":"Neurology"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1523\/JNEUROSCI.0996-12.2012","article-title":"ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications","volume":"32","author":"Hart","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng.2853","article-title":"Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models","volume":"46","author":"Kim","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"41310","DOI":"10.1074\/jbc.M112.398099","article-title":"Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS)","volume":"287","author":"Nihei","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Wijegunawardana, D., Nayak, A., Vishal, S.S., Venkatesh, N., and Gopal, P.P. (2024). Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43 ribonucleoprotein condensates disrupting mRNA transport and local translation in neurons. Dev. Cell.","DOI":"10.1016\/j.devcel.2024.09.023"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.neuron.2021.04.010","article-title":"Questioning the causality of HTT CAG-repeat expansions in FTD\/ALS","volume":"109","author":"Thomas","year":"2021","journal-title":"Neuron"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/17482968.2011.653573","article-title":"Prevalence of Huntington\u2019s disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients","volume":"13","author":"Ramos","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1212\/WNL.0b013e31821f4447","article-title":"Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis","volume":"76","author":"Lee","year":"2011","journal-title":"Neurology"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000478979","article-title":"Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders","volume":"44","author":"Bourbouli","year":"2017","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/17482968.2011.622405","article-title":"Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment","volume":"13","author":"Yang","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s40478-019-0816-1","article-title":"Synergistic toxicity in an in vivo model of neurodegeneration through the co-expression of human TDP-43(M337V) and tau(T175D) protein","volume":"7","author":"Moszczynski","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1750-1326-6-73","article-title":"Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice","volume":"6","author":"Xu","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/1980-57642016dn11-030006","article-title":"Distinct Phospho-TDP-43 brain distribution in two cases of FTD, one associated with ALS","volume":"11","author":"Guedes","year":"2017","journal-title":"Dement. Neuropsychol."},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Roberts, B., Theunissen, F., Mastaglia, F.L., Akkari, P.A., and Flynn, L.L. (2022). Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169364"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"e16206","DOI":"10.1111\/ene.16206","article-title":"Misfolded alpha-synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment","volume":"31","author":"Smith","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-019-0172-x","article-title":"Beyond the synucleinopathies: Alpha synuclein as a driving force in neurodegenerative comorbidities","volume":"8","author":"Visanji","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5692\/clinicalneurol.cn-001546","article-title":"Amyotrophic lateral sclerosis with muscle weakness and dropped head during the course of Parkinson\u2019s disease: An autopsy case","volume":"61","author":"Oda","year":"2021","journal-title":"Rinsho Shinkeigaku = Clin. Neurol."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Dhakal, S., Wyant, C.E., George, H.E., Morgan, S.E., and Rangachari, V. (2021). Prion-like C-Terminal Domain of TDP-43 and alpha-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils. J. Mol. Biol., 433.","DOI":"10.1101\/2020.12.12.422524"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Jamerlan, A.M., and An, S.S.A. (2022). A Microplate-Based Approach to Map Interactions between TDP-43 and alpha-Synuclein. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030573"},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Dhakal, S., Mondal, M., Mirzazadeh, A., Banerjee, S., Ghosh, A., and Rangachari, V. (2023). alpha-Synuclein emulsifies TDP-43 prion-like domain-RNA liquid droplets to promote heterotypic amyloid fibrils. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-05608-1"},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Dhakal, S., Robang, A.S., Bhatt, N., Puangmalai, N., Fung, L., Kayed, R., Paravastu, A.K., and Rangachari, V. (2022). Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with alpha-Synuclein. J. Biol. Chem., 298.","DOI":"10.1101\/2022.06.14.496041"},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Alamri, S.H., Haque, S., Alghamdi, B.S., Tayeb, H.O., Azhari, S., Farsi, R.M., Elmokadem, A., Alamri, T.A., Harakeh, S., and Prakash, A. (2023). Comprehensive mapping of mutations in TDP-43 and alpha-Synuclein that affect stability and binding. J. Biomol. Struct. Dyn., 1\u201313.","DOI":"10.1080\/07391102.2023.2293258"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 Pathology in Alzheimer\u2019s Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Lin","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40478-018-0641-y","article-title":"Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: Associations with Alzheimer\u2019s disease and cerebrovascular disease pathologies","volume":"6","author":"Katsumata","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","article-title":"Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer\u2019s disease: A longitudinal retrospective study","volume":"16","author":"Josephs","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bpa.12424","article-title":"TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing","volume":"27","author":"McAleese","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Mimuro, M., and Iwasaki, Y. (2024). Age-Related Pathology in Corticobasal Degeneration. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052740"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/neup.12723","article-title":"An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer\u2019s disease pathology","volume":"41","author":"Tando","year":"2021","journal-title":"Neuropathology"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.26809","article-title":"Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer\u2019s disease staging scheme","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia","volume":"139","author":"James","year":"2016","journal-title":"Brain J. Neurol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40478-020-00934-5","article-title":"Distinct molecular patterns of TDP-43 pathology in Alzheimer\u2019s disease: Relationship with clinical phenotypes","volume":"8","author":"Vandenberghe","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bpa.12505","article-title":"Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi","volume":"28","author":"Smith","year":"2018","journal-title":"Brain Pathol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2011.02.052","article-title":"beta-amyloid triggers ALS-associated TDP-43 pathology in AD models","volume":"1386","author":"Herman","year":"2011","journal-title":"Brain Res."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2017.04.012","article-title":"TDP-43 expression influences amyloidbeta plaque deposition and tau aggregation","volume":"103","author":"Davis","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2014.08.008","article-title":"Amyloid-beta oligomers as a template for secondary amyloidosis in Alzheimer\u2019s disease","volume":"71","author":"Krishnamurthy","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-023-00653-0","article-title":"TDP-43 pathology is associated with increased tau burdens and seeding","volume":"18","author":"Tsaka","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2017.05.037","article-title":"TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss","volume":"95","author":"Paolicelli","year":"2017","journal-title":"Neuron"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00401-016-1637-y","article-title":"Depletion of TDP-43 decreases fibril and plaque beta-amyloid and exacerbates neurodegeneration in an Alzheimer\u2019s mouse model","volume":"132","author":"LaClair","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"dmm049323","DOI":"10.1242\/dmm.049323","article-title":"TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans","volume":"15","author":"Latimer","year":"2022","journal-title":"Dis. Models Mech."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ana.26762","article-title":"Distinct Patterns of Hippocampal Pathology in Alzheimer\u2019s Disease with Transactive Response DNA-binding Protein 43","volume":"94","author":"Minogue","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"10600","DOI":"10.1074\/jbc.M117.783498","article-title":"Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies","volume":"292","author":"Gu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jnc.15450","article-title":"Phosphorylation of trans-active response DNA-binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing","volume":"158","author":"Wu","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_307","doi-asserted-by":"crossref","unstructured":"Jadhav, V.S., Stair, J.G., Eck, R.J., Smukowski, S.N., Currey, H.N., Toscano, L.G., Hincks, J.C., Latimer, C.S., Valdmanis, P.N., and Kraemer, B.C. (2024). Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets. Neurobiol. Dis., 193.","DOI":"10.1016\/j.nbd.2024.106441"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2014.03.075","article-title":"TDP-43 interaction with the intracellular domain of amyloid precursor protein induces p53-associated apoptosis","volume":"569","author":"Wang","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Riku, Y., Yoshida, M., Iwasaki, Y., Sobue, G., Katsuno, M., and Ishigaki, S. (2022). TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415755"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s12035-015-9264-5","article-title":"The Role of TDP-43 in Alzheimer\u2019s Disease","volume":"53","author":"Chang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000304041.09418.b1","article-title":"Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype","volume":"70","author":"Josephs","year":"2008","journal-title":"Neurology"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.24493","article-title":"TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features","volume":"78","author":"Josephs","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/NEN.0b013e31822c62cf","article-title":"Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease","volume":"70","author":"Tremblay","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2020.04.001","article-title":"Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer\u2019s disease: A case-control study","volume":"92","author":"Buciuc","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Koga, S., Zhou, X., Murakami, A., De Castro, C.F., Baker, M.C., Rademakers, R., and Dickson, D.W. (2022). Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology. Neuropathol. Appl. Neurobiol., 48.","DOI":"10.1111\/nan.12778"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","article-title":"TDP-43 pathology, cognitive decline, and dementia in old age","volume":"70","author":"Wilson","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","article-title":"Incidence and extent of TDP-43 accumulation in aging human brain","volume":"3","author":"Uchino","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_319","first-page":"e13213","article-title":"LATE-NC in Alzheimer\u2019s disease: Molecular aspects and synergies","volume":"34","author":"Gawor","year":"2023","journal-title":"Brain Pathol."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/brain\/awaa219","article-title":"Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration","volume":"143","author":"Robinson","year":"2020","journal-title":"Brain J. Neurol."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"122894","DOI":"10.1016\/j.jns.2024.122894","article-title":"The influence of limbic-predominant age-related TDP-43 encephalopathy on argyrophilic grain disease: A voxel-based morphometry analysis of pathologically confirmed cases","volume":"457","author":"Inui","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.29048","article-title":"TDP-43 Proteinopathy Presenting with Typical Symptoms of Parkinson\u2019s Disease","volume":"37","author":"Yamashita","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7150\/ijbs.7.234","article-title":"TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice","volume":"7","author":"Tian","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Shen, L., Wang, C., Chen, L., Leung, K.L., Lo, E., Lakso, M., and Wong, G. (2020). TDP-1\/TDP-43 potentiates human alpha-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165876"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","article-title":"Pathological alpha-synuclein propagates through neural networks","volume":"2","author":"Nonaka","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-015-0038-3","article-title":"Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation","volume":"10","author":"Kiely","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s00018-019-03059-8","article-title":"Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models","volume":"76","author":"Coudert","year":"2019","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","article-title":"Interaction with polyglutamine aggregates reveals a Q\/N-rich domain in TDP-43","volume":"285","author":"Fuentealba","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Nguyen, T.B., Miramontes, R., Chillon-Marinas, C., Maimon, R., Vazquez-Sanchez, S., Lau, A.L., McClure, N.R., England, W.E., Singha, M., and Stocksdale, J.T. (2023). Aberrant splicing in Huntington\u2019s disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification. bioRxiv.","DOI":"10.1101\/2023.10.31.565004"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"e140723","DOI":"10.1172\/JCI140723","article-title":"Huntington\u2019s disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization","volume":"131","author":"Sanchez","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/hmg\/dds485","article-title":"Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington\u2019s disease models","volume":"22","author":"Tauffenberger","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Canet-Pons, J., Sen, N.-E., Arsovi\u0107, A., Almaguer-Mederos, L.-E., Halbach, M.V., Key, J., D\u00f6ring, C., Kerksiek, A., Picchiarelli, G., and Cassel, R. (2021). Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol. Dis., 152.","DOI":"10.1016\/j.nbd.2021.105289"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ng.293","article-title":"DCTN1 mutations in Perry syndrome","volume":"41","author":"Farrer","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_334","doi-asserted-by":"crossref","unstructured":"Mishima, T., Yuasa-Kawada, J., Fujioka, S., and Tsuboi, Y. (2024). Perry Disease: Bench to Bedside Circulation and a Team Approach. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010113"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","article-title":"Pallidonigral TDP-43 pathology in Perry syndrome","volume":"15","author":"Wider","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jnen\/nlx049","article-title":"Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy","volume":"76","author":"Mishima","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/mdc3.13235","article-title":"Neuropathology of Perry Syndrome: Evidence of Medullary and Hypothalamic Involvement","volume":"8","author":"Kim","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_338","doi-asserted-by":"crossref","unstructured":"Deshimaru, M., Kinoshita-Kawada, M., Kubota, K., Watanabe, T., Tanaka, Y., Hirano, S., Ishidate, F., Hiramoto, M., Ishikawa, M., and Uehara, Y. (2021). DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083985"},{"key":"ref_339","doi-asserted-by":"crossref","unstructured":"Versluys, L., Pereira, P.E., Schuermans, N., De Paepe, B., De Bleecker, J.L., Bogaert, E., and Dermaut, B. (2022). Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.815765"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10238-024-01353-9","article-title":"Inclusion body myositis, viral infections, and TDP-43: A narrative review","volume":"24","author":"Vulturar","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00401-023-02565-1","article-title":"C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS\/FTD","volume":"145","author":"Pereira","year":"2023","journal-title":"Acta Neuropathol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12380\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:34:41Z","timestamp":1760114081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":341,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252212380"],"URL":"https:\/\/doi.org\/10.3390\/ijms252212380","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]}}}